Inventage Lab, Inc. (KOSDAQ: A389470)
Health Care · Biotechnology · KR
₩26,600.00
-6.01% today · -36.4% 1Y
Inventage Lab, Inc. (KOSDAQ: A389470) operates in the Biotechnology industry within the Health Care sector. The company is valued at $263.31M.
Over the last twelve months the share price has lost 36.4%, trading between 22.65K and 101.70K.
Tweenvest scores Inventage Lab, Inc. across four factors: quality 48/100, value 44/100. Its strongest factor is quality.
A389470 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $263.31M
- Revenue (TTM)
- $1.60M
- P/E
- —
- EPS
- -252.47
- Dividend yield
- —
- Beta (5Y)
- 0.92
- 52-week high
- ₩101,700.00
- 52-week low
- ₩22,650.00
- Avg volume (3M)
- —
- Shares outstanding
- 13.31M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Century Therapeutics, Inc.NasdaqCM: IPSC | $266.18M | $1.47 | -3.92% |
| Mabpharm LimitedSEHK: 2181 | $265.39M | HK$0.51 | +3.06% |
| BridgeBio Oncology Therapeutics, Inc.NasdaqGM: BBOT | $265.38M | $3.31 | -14.91% |
| Lexeo Therapeutics, Inc.NasdaqGM: LXEO | $265.00M | $3.23 | -8.50% |
| Santhera Pharmaceuticals Holding AGSWX: SANN | $263.01M | CHF14.56 | +1.96% |
| Obigen Pharma Inc.TPEX: 7876 | $262.25M | NT$78.20 | +21.81% |
| Anika Therapeutics, Inc.NasdaqGS: ANIK | $262.04M | $19.58 | +1.82% |
| Fate Therapeutics, Inc.NasdaqGM: FATE | $261.21M | $2.11 | -3.21% |
Figures last refreshed Oct 11, 2026.